Perfil
Nanette Cocero currently works at PharmaJet, Inc., as Director from 2023.
Dr. Cocero also formerly worked at HilleVax, Inc., as Independent Director from 2023 to 2025 and Pfizer Vaccines LLC, as Global President from 2019 to 2022.
Dr. Cocero received her doctorate degree from the University of Pennsylvania, undergraduate degree from Cornell University, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Cargos activos de Nanette Cocero
| Empresas | Cargo | Inicio |
|---|---|---|
PharmaJet, Inc.
PharmaJet, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops needle-free injection technology | Director/Miembro de la Junta | 11/07/2023 |
Antiguos cargos conocidos de Nanette Cocero.
| Empresas | Cargo | Fin |
|---|---|---|
| HILLEVAX, INC. | Director/Miembro de la Junta | 17/09/2025 |
Pfizer Vaccines LLC | Presidente | 01/12/2022 |
Formación de Nanette Cocero.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
PharmaJet, Inc.
PharmaJet, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops needle-free injection technology | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Vaccines LLC | |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HilleVax, Inc.
HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
- Bolsa de valores
- Insiders
- Nanette Cocero
















